Garza, Maryam Y.
Williams, Tremaine B.
Ounpraseuth, Songthip
Hu, Zhuopei
Lee, Jeannette
Snowden, Jessica
Walden, Anita C.
Simon, Alan E.
Devlin, Lori A.
Young, Leslie W.
Zozus, Meredith N.
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR003107)
National Institutes of Health (U24OD024957)
Article History
Received: 14 March 2023
Accepted: 26 November 2024
First Online: 18 December 2024
Declarations
:
: The ACT NOW CE Study (parent study; IRB#217689) was reviewed and approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (IRB). The parent study received a HIPAA waiver, as well as a waiver for informed consent/assent. The quality control study and meta-analysis received a determination of not human subjects research as defined in 45 CFR 46.102 by the UAMS IRB (IRB#239826). All methods were carried out in accordance with relevant guidelines and regulations.
: Not Applicable.
: The authors declare no competing interests.